STING1 and neoplasm: To verify this hypothesis, we rechallenged cured mice with 4T1 cells on day 50 after treatment and monitored tumor growth and found that the tumors did not grow in the cured mice (Figure 5P), which indicated that PmTriTNE could act in synergy with the STING agonist to efficiently generate antitumor immune memory responses.